With a P/E ratio of 8 and selling for pennies, is this FTSE 250 share a bargain?

Christopher Ruane digs into a cheap-looking FTSE 250 share that sells an iconic product and considers whether it’s really a bargain for his portfolio.

| More on:
Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

One common way to value shares is to look at their price-to-earnings (P/E) ratio. As a rule of thumb, the lower it is, the cheaper the share is, although there are a couple of important caveats to consider: the sustainability of the earnings and the firm’s debt both matter. At the moment, one well-known FTSE 250 share sells for pennies and has a P/E ratio of just 8.

So, is it a bargain I ought to buy for my portfolio?

Well-known consumer brand

The share in question is Dr Martens (LSE: DOCS).

With an iconic footwear brand, large customer base, and unique place in the market, I think there is a lot to like about the business.

So, why is the FTSE 250 share selling for pennies? (And why has it fallen 88% since it listed on the London stock market just three years ago?)

The answer lies in the firm’s weak performance lately.

Take last year as an example. Revenues fell by 12%. Profit after tax crashed by 46%.

Created using TradingView

Meanwhile, net debt rose by 24%. As I said above, debt matters when it comes to valuation as servicing and repaying it can eat into earnings.

Potential for turnaround

Still, while the company’s profits after tax fell badly, it remained firmly in the black. It cut the dividend, but did not cancel it altogether.

Created using TradingView

Weak US consumer demand was given as a key reason for last year’s poor performance. But the business announced plans to address that, including increasing marketing spend in the crucial region.

The most recent update came in July, when the company said that trading in its most recent quarter had been in line with expectations. I think a big test will come this month, when Dr Martens is set to announce its interim results.

If they contain positive news about sales trends and costs, I reckon the current share price could turn out to be a bargain.

However, the reverse could happen. If there are only weak signs of a turnaround (or none at all), the share price may fall further. Dr Martens shoes are not cheap and US consumer spending remains fairly weak.

I’m not buying

I am in no rush to buy here. The company’s huge share price decline since listing points to a number of factors that concern me, from net debt to the seeming fragility of the business model.

At best, I think the business can start to show evidence of a turnaround and see the share price climb. But any such turnaround is unlikely to happen overnight. So there will likely be time for me to buy when evidence of it comes, even if that means paying a higher price than today for the FTSE 250 share.

Meanwhile, the risks concern me. Dr Martens is a strong brand but it is a business that has been battling sizeable challenges. Those may continue.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

C Ruane has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Abstract bull climbing indicators on stock chart
Investing Articles

3 S&P 500 stocks that could surge under Donald Trump as US president

These three S&P 500 companies are all set to benefit from Trump’s planned policies, so they might be set to…

Read more »

Investing Articles

£5,000 invested in a FTSE 250 index fund during Covid would be worth this now

Zaven Boyrazian looks at the FTSE 250 index’s performance since the pandemic ravaged the world. Has an index fund been…

Read more »

Investing Articles

£5,000 invested in the FTSE 100 at the start of 2024 would be worth this now

The FTSE 100's up by double-digits, but it’s Britain’s banks that are stealing the show. Here’s how much profit investors…

Read more »

Man smiling and working on laptop
Investing Articles

2 high-yield dividend shares to consider for a BIG second income in 2025

Looking for ways to make a market-beating second income next year? You might want to take a look at these…

Read more »

Smiling diverse couple holding Christmas presents while walking through a winter forest
Investing Articles

2 FTSE 100 and FTSE 250 value stocks to consider in December!

Searching for the best FTSE 100 and FTSE 250 bargain shares? Here, Royston Wild picks out two of his favourites…

Read more »

Investing Articles

3 mega-cheap small-cap stocks to consider in December!

These small-cap stocks are on sale right now. Royston Wild thinks they merit serious attention, even from investors chasing passive…

Read more »

White female supervisor working at an oil rig
Growth Shares

Based on these oil price forecasts, the BP share price could have a tough 2025

Jon Smith explains why he thinks a stagnant oil price could be a problem for the BP share price over…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing For Beginners

This AI penny stock could be set to explode higher in 2025

Jon Smith spots a penny stock that's secured a couple of large contracts recently and that he thinks could be…

Read more »